期刊文献+

心源性脑梗死与非心源性脑梗死患者rt-PA静脉溶栓治疗效果比较 被引量:2

Comparison of clinical effects of rt-PA intravenous thrombolysis therapy in patients with cardiogenic cerebral infarction and non-cardiac cerebral infarction
原文传递
导出
摘要 目的比较重组组织型纤溶酶原激活剂(rt-PA)静脉溶栓治疗对非心源性脑梗死与心源性脑梗死患者的临床疗效。方法选取2016年7月至2018年5月于武陟县中医院就诊的74例心源性脑梗死患者为A组,74例非心源性脑梗死患者为B组。两组患者均接受rt-PA静脉溶栓治疗。采用美国国立卫生研究院卒中量表(NIHSS)评估两组治疗前、治疗后2 h、治疗后1 d、治疗后1周神经功能缺损程度,对比两组并发症发生情况。结果治疗后2 h、治疗后1 d、治疗后1周,两组NIHSS评分均呈下降趋势,组间比较差异无统计学意义(均P>0.05)。A组脑疝、皮肤黏膜出血发生率及并发症总发生率均高于B组,差异有统计学意义(均P<0.05)。结论 rt-PA静脉溶栓治疗在改善心源性脑梗死与非心源性脑梗死患者神经功能方面效果相当,心源性脑梗死患者溶栓后并发症(皮肤黏膜出血、脑疝等)发生率较高。 Objective To compare the clinical effects of recombinant tissue plasminogen activator(rt-PA)intravenous thrombolysis in patients with non-cardiac cerebral infarction and cardiogenic cerebral infarction.Methods Seventy-four patients with cardiogenic cerebral infarction who were admitted to Wuzhi County Traditional Chinese Medicine Hospital from July 2016 to May 2018 were selected as group A,and 74 patients with non-cardiac cerebral infarction were group B.All the patients received rt-PA intravenous thrombolysis therapy.The National Institute of Health Stroke Scale(NIHSS)was used to evaluate the degree of neurological deficits before treatment,2 h after treatment,1 d after treatment,and 1 week after treatment.The complications of the two groups were compared.Results The NIHSS scores of the two groups showed a downward trend 2 h,1 d and 1 week after treatment.There was no significant difference between the two groups(all P>0.05).The incidence of cerebral hernia,skin mucosal bleeding,and the total incidence of complications in group A were higher than those in group B(all P<0.05).Conclusion The clinical effect of rt-PA intravenous thrombolysis in patients with cardiogenic cerebral infarction is commensurate with that in patients with non-cardiac cerebral infarction.Patients with cardiogenic cerebral infarction have a higher incidence of complications after thrombolysis.
作者 朱长保 Zhu Changbao(Internal Medicine Department,Wuzhi County Traditional Chinese Medicine Hospital,Jiaozuo 454950,China)
出处 《中华心脏与心律电子杂志》 2019年第2期71-73,共3页 Chinese Journal of Heart and Heart Rhythm(Electronic Edition)
关键词 心源性脑梗死 非心源性脑梗死 静脉溶栓 Cardiogenic cerebral infarction Non-cardiac cerebral infarction intravenous thrombolysis
  • 相关文献

参考文献4

二级参考文献47

  • 1高建国,周农,翟金霞.血清C反应蛋白水平与脑梗死预后的关系[J].临床神经病学杂志,2005,18(1):43-44. 被引量:113
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33024
  • 3王雪里红,曾红,樊琨,王克英,左鹰,王沈燕,胡南,李学英,赵永春,王洪源.重组组织型纤溶酶原激活剂早期静脉溶栓对急性脑梗死的疗效[J].中华神经科杂志,2006,39(10):678-683. 被引量:62
  • 4张祎年,何宁.缺血性脑梗死前期的临床及影像学研究进展[J].实用放射学杂志,2007,23(10):1419-1421. 被引量:1
  • 5Sugiura S,Lwaisako K,Toyota S,et a1.Simultaneous treatment with intravenous recombinan t tissue plasminogen activator and endovascular therapy for acute ischemic stroke within 3 hours of onset.Am J Neuroradiol,2008,29:1061-1066.
  • 6Tissue P1asminogen activator for acute ischemic stroke.The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.N Ensl J Med,1995,333:1581-1587.
  • 7中国急性缺血性脑卒中诊治指南2010.中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中华神经科杂志,2010,43:146-152.
  • 8Bivard A,Spratt N,Levi CR,et al.Acute stroke thrombolysis:time to dispense with the clock and move to tissue-based decision making?Expert Rev Cardiovasc Ther,2011,9:451-461.
  • 9Wahlgren N,Ahmed N,Davalos A,et al.Thrombolysis with alteplase for acute ischemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study(SITS-MOST):an observation study.Lancet,2007,369:275-282.
  • 10Shobha N,Buchan AM,Hill MD.Thrombolysis at 3-4.5 hours after acute ischemic stroke onset-evidence from the Canadian Alteplase for Stroke Effectiveness Study(CASES)registry.Cerebrovasc Dis,2011,31:223-228.

共引文献75

同被引文献18

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部